Replication data for: Private Provision of Social Insurance: Drug-Specific Price Elasticities and Cost Sharing in Medicare Part D

Principal Investigator(s): View help for Principal Investigator(s) Liran Einav; Amy Finkelstein; Maria Polyakova

Name	File Type	Size	Last Modified
Pol2016-0355_data			10/13/2019 05:39:AM
LICENSE.txt	text/plain	14.6 KB	10/13/2019 01:39:AM

Project Citation:

Einav, Liran, Finkelstein, Amy, and Polyakova, Maria. Replication data for: Private Provision of Social Insurance: Drug-Specific Price Elasticities and Cost Sharing in Medicare Part D. Nashville, TN: American Economic Association [publisher], 2018. Ann Arbor, MI: Inter-university Consortium for Political and Social Research [distributor], 2019-10-13. https://doi.org/10.3886/E114695V1

Project Description

Summary: We explore how private drug plans set cost sharing in the context of Medicare Part D. While publicly provided drug coverage typically involves uniform cost sharing across drugs, we document substantial heterogeneity in the cost sharing for different drugs within privately provided plans. We also document that private plans systematically set higher consumer cost sharing for drugs or classes associated with more elastic demand; to do so, we estimate price elasticities of demand across more than 150 drugs and across more than 100 therapeutic classes. We conclude by discussing the various channels that likely affect private plans' cost-sharing decisions.

Scope of Project

JEL Classification:
      G22 Insurance; Insurance Companies; Actuarial Studies
      H51 National Government Expenditures and Health
      I13 Health Insurance, Public and Private
      I18 Health: Government Policy; Regulation; Public Health
      L11 Production, Pricing, and Market Structure; Size Distribution of Firms
      L65 Chemicals; Rubber; Drugs; Biotechnology; Plastics

Related Publications

Download this project

Published Versions

V1 [2019-10-13]

Export Metadata

Dublin Core

DDI 2.5

Report a Problem

Found a serious problem with the data, such as disclosure risk or copyrighted content? Let us know.

This material is distributed exactly as received from the data depositor. As of April 2026, depositors are required to submit study materials in accessible formats. ICPSR has not reviewed, checked, or processed this material. For additional information about the study, please contact the investigator(s) directly. If you have questions about the accessibility of materials distributed by ICPSR or require further assistance, please visit ICPSR's Accessibility Center.